| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Retension Pharmaceuticals, Inc.
13D
RTSN · 76135H100
|
7.1% |
10/14/2026
Event 10/13/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.